Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder

There are currently five programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors approved for the treatment of locally advanced or metastatic urothelial carcinoma (UC) of the bladder. For platinum-ineligible patients, testing of tumor specimens for PD-L1 expression is required. Howeve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tosev, Georgi (VerfasserIn) , Wahafu, Wasilijiang (VerfasserIn) , Reimold, Philipp (VerfasserIn) , Damgov, Ivan (VerfasserIn) , Schwab, Constantin (VerfasserIn) , Aksoy, Cem (VerfasserIn) , Kaczorowski, Adam (VerfasserIn) , Stenzinger, Albrecht (VerfasserIn) , Nyarangi-Dix, Joanne (VerfasserIn) , Hohenfellner, Markus (VerfasserIn) , Duensing, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 9 July 2021
In: Scientific reports
Year: 2021, Jahrgang: 11, Pages: 1-6
ISSN:2045-2322
DOI:10.1038/s41598-021-93754-z
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41598-021-93754-z
Volltext
Verfasserangaben:Georgi Tosev, Wasilijiang Wahafu, Philipp Reimold, Ivan Damgov, Constantin Schwab, Cem Aksoy, Adam Kaczorowski, Albrecht Stenzinger, Joanne Nyarangi-Dix, Markus Hohenfellner & Stefan Duensing

MARC

LEADER 00000caa a2200000 c 4500
001 1767105061
003 DE-627
005 20230426082439.0
007 cr uuu---uuuuu
008 210816s2021 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41598-021-93754-z  |2 doi 
035 |a (DE-627)1767105061 
035 |a (DE-599)KXP1767105061 
035 |a (OCoLC)1341420687 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Tosev, Georgi  |e VerfasserIn  |0 (DE-588)1098138333  |0 (DE-627)857783084  |0 (DE-576)468966455  |4 aut 
245 1 0 |a Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder  |c Georgi Tosev, Wasilijiang Wahafu, Philipp Reimold, Ivan Damgov, Constantin Schwab, Cem Aksoy, Adam Kaczorowski, Albrecht Stenzinger, Joanne Nyarangi-Dix, Markus Hohenfellner & Stefan Duensing 
264 1 |c 9 July 2021 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.08.2021 
520 |a There are currently five programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors approved for the treatment of locally advanced or metastatic urothelial carcinoma (UC) of the bladder. For platinum-ineligible patients, testing of tumor specimens for PD-L1 expression is required. However, scoring of PD-L1 immunohistochemistry is complex due to different antibodies used, the requirement to score expression in different cellular compartments and intratumoral heterogeneity. It can also be difficult to obtain and test longitudinal tumor samples, which would be desirable to monitor treatment responses and tumor evolution under treatment-induced selective pressure. In the present proof-of concept study, we provide evidence that PD-L1 can be detected in the urine of patients with non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). Urine PD-L1 levels were significantly higher in NMIBC and MIBC patients when compared to patients with various non-malignant urological diseases. Further prospective and independent studies are required to assess the value of PD-L1 in the urine as a novel biomarker with potential for the early detection, prediction and therapeutic monitoring of patients with UC of the bladder. 
700 1 |a Wahafu, Wasilijiang  |e VerfasserIn  |4 aut 
700 1 |a Reimold, Philipp  |e VerfasserIn  |0 (DE-588)1205514376  |0 (DE-627)1691191469  |4 aut 
700 1 |a Damgov, Ivan  |d 1992-  |e VerfasserIn  |0 (DE-588)1239075308  |0 (DE-627)1767106246  |4 aut 
700 1 |a Schwab, Constantin  |d 1992-  |e VerfasserIn  |0 (DE-588)1106892291  |0 (DE-627)863243045  |0 (DE-576)474954269  |4 aut 
700 1 |a Aksoy, Cem  |e VerfasserIn  |0 (DE-588)1205514759  |0 (DE-627)1691192147  |4 aut 
700 1 |a Kaczorowski, Adam  |e VerfasserIn  |0 (DE-588)1062747550  |0 (DE-627)806827742  |0 (DE-576)420146318  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Nyarangi-Dix, Joanne  |d 1978-  |e VerfasserIn  |0 (DE-588)135726956  |0 (DE-627)570570158  |0 (DE-576)300611951  |4 aut 
700 1 |a Hohenfellner, Markus  |d 1958-  |e VerfasserIn  |0 (DE-588)133862518  |0 (DE-627)557857988  |0 (DE-576)300155263  |4 aut 
700 1 |a Duensing, Stefan  |d 1967-  |e VerfasserIn  |0 (DE-588)1074044487  |0 (DE-627)830213007  |0 (DE-576)435550098  |4 aut 
773 0 8 |i Enthalten in  |t Scientific reports  |d [London] : Springer Nature, 2011  |g 11(2021), Artikel-ID 14244, Seite 1-6  |h Online-Ressource  |w (DE-627)663366712  |w (DE-600)2615211-3  |w (DE-576)346641179  |x 2045-2322  |7 nnas  |a Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder 
773 1 8 |g volume:11  |g year:2021  |g elocationid:14244  |g pages:1-6  |g extent:6  |a Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder 
856 4 0 |u https://doi.org/10.1038/s41598-021-93754-z  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20210816 
993 |a Article 
994 |a 2021 
998 |g 1074044487  |a Duensing, Stefan  |m 1074044487:Duensing, Stefan  |d 910000  |d 910200  |e 910000PD1074044487  |e 910200PD1074044487  |k 0/910000/  |k 1/910000/910200/  |p 11  |y j 
998 |g 133862518  |a Hohenfellner, Markus  |m 133862518:Hohenfellner, Markus  |d 910000  |d 910200  |e 910000PH133862518  |e 910200PH133862518  |k 0/910000/  |k 1/910000/910200/  |p 10 
998 |g 135726956  |a Nyarangi-Dix, Joanne  |m 135726956:Nyarangi-Dix, Joanne  |d 910000  |d 910200  |e 910000PN135726956  |e 910200PN135726956  |k 0/910000/  |k 1/910000/910200/  |p 9 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 8 
998 |g 1062747550  |a Kaczorowski, Adam  |m 1062747550:Kaczorowski, Adam  |d 910000  |d 910200  |e 910000PK1062747550  |e 910200PK1062747550  |k 0/910000/  |k 1/910000/910200/  |p 7 
998 |g 1205514759  |a Aksoy, Cem  |m 1205514759:Aksoy, Cem  |d 910000  |d 910200  |e 910000PA1205514759  |e 910200PA1205514759  |k 0/910000/  |k 1/910000/910200/  |p 6 
998 |g 1106892291  |a Schwab, Constantin  |m 1106892291:Schwab, Constantin  |d 910000  |d 912000  |e 910000PS1106892291  |e 912000PS1106892291  |k 0/910000/  |k 1/910000/912000/  |p 5 
998 |g 1239075308  |a Damgov, Ivan  |m 1239075308:Damgov, Ivan  |d 910000  |d 910500  |e 910000PD1239075308  |e 910500PD1239075308  |k 0/910000/  |k 1/910000/910500/  |p 4 
998 |g 1205514376  |a Reimold, Philipp  |m 1205514376:Reimold, Philipp  |d 910000  |d 910200  |e 910000PR1205514376  |e 910200PR1205514376  |k 0/910000/  |k 1/910000/910200/  |p 3 
998 |g 1098138333  |a Tosev, Georgi  |m 1098138333:Tosev, Georgi  |d 910000  |d 910200  |e 910000PT1098138333  |e 910200PT1098138333  |k 0/910000/  |k 1/910000/910200/  |p 1  |x j 
999 |a KXP-PPN1767105061  |e 3969334187 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"6 S."}],"id":{"eki":["1767105061"],"doi":["10.1038/s41598-021-93754-z"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 16.08.2021"],"relHost":[{"note":["Gesehen am 12.07.24"],"part":{"pages":"1-6","year":"2021","extent":"6","text":"11(2021), Artikel-ID 14244, Seite 1-6","volume":"11"},"id":{"eki":["663366712"],"issn":["2045-2322"],"zdb":["2615211-3"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Scientific reports","title_sort":"Scientific reports"}],"origin":[{"publisher":"Springer Nature ; Nature Publishing Group","dateIssuedDisp":"2011-","dateIssuedKey":"2011","publisherPlace":"[London] ; London"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1, article number 1 (2011)-"],"language":["eng"],"recId":"663366712","disp":"Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladderScientific reports"}],"person":[{"family":"Tosev","given":"Georgi","display":"Tosev, Georgi","role":"aut"},{"family":"Wahafu","given":"Wasilijiang","display":"Wahafu, Wasilijiang","role":"aut"},{"role":"aut","family":"Reimold","display":"Reimold, Philipp","given":"Philipp"},{"display":"Damgov, Ivan","given":"Ivan","family":"Damgov","role":"aut"},{"role":"aut","given":"Constantin","display":"Schwab, Constantin","family":"Schwab"},{"role":"aut","family":"Aksoy","display":"Aksoy, Cem","given":"Cem"},{"role":"aut","given":"Adam","display":"Kaczorowski, Adam","family":"Kaczorowski"},{"family":"Stenzinger","given":"Albrecht","display":"Stenzinger, Albrecht","role":"aut"},{"family":"Nyarangi-Dix","display":"Nyarangi-Dix, Joanne","given":"Joanne","role":"aut"},{"role":"aut","given":"Markus","display":"Hohenfellner, Markus","family":"Hohenfellner"},{"role":"aut","family":"Duensing","given":"Stefan","display":"Duensing, Stefan"}],"name":{"displayForm":["Georgi Tosev, Wasilijiang Wahafu, Philipp Reimold, Ivan Damgov, Constantin Schwab, Cem Aksoy, Adam Kaczorowski, Albrecht Stenzinger, Joanne Nyarangi-Dix, Markus Hohenfellner & Stefan Duensing"]},"origin":[{"dateIssuedDisp":"9 July 2021","dateIssuedKey":"2021"}],"recId":"1767105061","title":[{"title_sort":"Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder","title":"Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder"}],"language":["eng"]} 
SRT |a TOSEVGEORGDETECTIONO9202